HDGFL2 and malaria: Studies have shown persistence of HRP2 in the plasma up to 28 days after treatment particularly in high parasitaemia infections33, in that case, a person can have a new infection with P. falciparum parasites lacking pfhrp2/3 genes but have a circulating HRP2 from the previous infection commonly observed in areas with high malaria transmission.